Remove 2021 Remove Article Remove Packaging
article thumbnail

Pharma in Brief: The 2021 Year in Review

Pharma in Brief

In this article, the Pharma in Brief team has curated and provided updates on the most significant topics we covered in 2021. In 2021, governments advanced major policy initiatives aimed at the COVID-19 pandemic and broader health priorities. The courts also had a busy year in 2021. Introduction.

article thumbnail

Global manufacturing capacity for active pharmaceutical ingredients remains concentrated

Quality Matters

Food and Drug Administration (FDA) by API manufacturers to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products. This is an update to an analysis of API DMFs that we conducted in 2021.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Registration opens for Pre-filled Syringes & Injectable Devices Conference 2021

pharmaphorum

SMi Reports: Registration is open for SMi Group’s 13 th annual conference and exhibition taking place in January 2021. 13 th – 14 th January 2021. The post Registration opens for Pre-filled Syringes & Injectable Devices Conference 2021 appeared first on. The pre-filled syringes industry is growing at an exponential rate.

article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

The removal appears to be in response to the publication of a 2021 article in the International Journal of Pharmaceutical Compounding. .” How is this possible when we all have referred to this list as the “ISMP’s Do Not Crush List” for over a decade?

Dosage 111
article thumbnail

After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023

Pharmaceutical Technology

PWC predicts deal volumes to resemble prior years with the effect of the US Inflation Reduction Act on pricing better understood and less uncertainty surrounding business conditions, according to an article entitled Pharmaceutical & Life Sciences: US Deals 2023 Outlook published on the company’s website. Catalent Inc.

article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

The removal appears to be in response to the publication of a 2021 article in the International Journal of Pharmaceutical Compounding. .” How is this possible when we all have referred to this list as the “ISMP’s Do Not Crush List” for over a decade?

Dosage 52
article thumbnail

October 2023 Newsletter

Safe Biologics

A 2021 survey of 401 U.S REMINDER: FDA Draft Guidance Would Remove Interchangeability Statement from Interchangeable Biosimilars Comments Due November 17th On September 15th, the Food and Drug Administration (FDA) released draft guidance removing the interchangeability statement from the product label/package insert. and worldwide.”